Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

Clinical trial NCT04721002 · COMPLETED

Trial details

NCT number: NCT04721002
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma (MM)

Start date: 2021-07-07
Primary completion: 2023-09-30
Enrollment: 514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.